Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Feb 21;18(1):55.
doi: 10.1186/s12877-018-0738-y.

Stroke as an atypical initial presentation of giant cell arteritis

Affiliations
Case Reports

Stroke as an atypical initial presentation of giant cell arteritis

Tharsika Kuganesan et al. BMC Geriatr. .

Abstract

Background: Giant cell arteritis (GCA) is an immune mediated inflammatory disease of medium and large arteries which afflicts older people. The classical presentation features include: headache, visual disturbances, and jaw claudication. Patients diagnosed with GCA have also been observed to be at higher risk for the subsequent development of strokes.

Case presentation: We describe a case of an 84-year old right-handed man who presented to hospital with dysarthria, dysphagia, right-sided facial drop, a history of generalized weakness and multiple falls. He was admitted to geriatric medicine with the working diagnosis of a posterior circulation stroke syndrome. He was also started on antibiotic treatment for a possible community-acquired pneumonia because of the presence of a low-grade fever and a chest radiograph showing ill-defined left lower lobe airspace disease. Initial lab results were remarkable for an erythrocyte sedimentation rate (ESR) of 112 mm/h and a C-reactive protein (CRP) level of 110 mg/L consistent with an active inflammatory state. Neurovascular imaging showed mild atherosclerotic changes of the aortic arch and proximal great vessels without significant stenosis. The patient was started on daily high-dose prednisone because of the possibility of a cerebral vasculitis. Bilateral biopsy of temporal arteries showed giant cell arteritis. The patient's neurologic status and inflammatory markers significantly improved (ESR 52 mm/h, CRP 7.0 mg/L) and he was eventually discharged to a seniors home with services.

Conclusion: The initial presentation of giant cell arteritis as a stroke syndrome, especially in the posterior circulation territory, is exceedingly rare. Other atypical presenting symptoms may include chronic cough and fever of unknown origin. The elevated ESR and CRP levels were clues to the diagnosis and clinical decision-making should be driven by a high index of suspicion since no single test (ESR, CRP, temporal artery biopsy) has perfect sensitivity. Elevated CRP may have a role in increasing stroke risk. This case report illustrates that in older people clinicians must consider atypical presentations of disease more often since timely diagnosis and initiation of treatment can result in optimal outcomes.

Keywords: Atypical presentation; Giant cell arteritis; Stroke.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

Informed consent, both verbal and written was obtained from the patient and his legally recognized substitute decision maker for publication of the case, the lab results and biopsy results and images.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Photomicrograph of a hematoxylin and eosin stained section of the temporal artery biopsy, showing transmural inflammation (square brackets). The arrow indicates the arterial lumen. The solid bar represents 400 μm
Fig. 2
Fig. 2
Close-up of a multi-nucleated giant cell (arrow). The solid bar represents 100 μm

Similar articles

Cited by

References

    1. Weyand CM, Goronzy JJ. Giant-cell Arteritis and Polymyalgia Rheumatica. N Engl J Med. 2014;371:50–57. doi: 10.1056/NEJMcp1214825. - DOI - PMC - PubMed
    1. Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev. 2012;11:A544–A554. doi: 10.1016/j.autrev.2012.01.003. - DOI - PubMed
    1. Samson M, Jacquin A, Audia S, Daubail B, Devilliers H, Petrella T, et al. Stroke associated with giant cell arteritis: a population-based study. J Neurol Neurosurg Psychiatry. 2015;86:216. doi: 10.1136/jnnp-2014-307614. - DOI - PubMed
    1. Nesher G. Neurologic manifestations of giant cell arteritis. Clin Exp Rheumatol. 2000;18:s24–s26. - PubMed
    1. Salvarani C, Bella CD, Cimino L, Macchioni P, Formisano D, Bajocchi G, et al. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology. 2009;48:250–253. doi: 10.1093/rheumatology/ken465. - DOI - PubMed

Publication types